Cargando…

Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas

Hepatoma-derived growth factor (HDGF) regulates various cellular processes involved in the onset and development of tumors. To evaluate the role of HDGF in human gliomas, western blotting analysis, immunohistochemistry staining and reverse transcription-quantitative polymerase chain reaction were pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Liang, Shengru, Li, Yuqian, Gao, Fei, Zheng, Longlong, Tian, Shilai, Yang, Pu, Li, Lihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754909/ https://www.ncbi.nlm.nih.gov/pubmed/29344149 http://dx.doi.org/10.3892/ol.2017.7180

Ejemplares similares

Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer
por: Liu, Xue-jun, et al.
Publicado: (2015)

Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas
por: Song, Zi-Bin, et al.
Publicado: (2020)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

Effects of early administration of insulin-like growth factor-1 on cognitive function in septic encephalopathy
por: Yang, Yang, et al.
Publicado: (2019)

Upregulated necroptosis-pathway-associated genes are unfavorable prognostic markers in low-grade glioma and glioblastoma multiforme
por: Dong, Yuanli, et al.
Publicado: (2019)

Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma
por: Wang, Haiwei, et al.
Publicado: (2021)

Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen
por: Everett, Allen D, et al.
Publicado: (2011)

GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer
por: Yang, Jing, et al.
Publicado: (2016)

Hepatoma-Derived Growth Factor Upregulation Is Correlated with Prognostic Factors of Early-Stage Cervical Adenocarcinoma
por: Tsai, Ching-Chou, et al.
Publicado: (2014)

Hepatoma derived growth factor binds DNA through the N-terminal PWWP domain
por: Yang, Jun, et al.
Publicado: (2007)

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor
por: Wang, Zhi-liang, et al.
Publicado: (2018)

Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer
por: Lian, Jiayan, et al.
Publicado: (2015)

A Positive Dermcidin Expression Is an Unfavorable Prognostic Marker for Extramammary Paget’s Disease
por: Ohmori, Shun, et al.
Publicado: (2021)

The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye
por: LeBlanc, Michelle E., et al.
Publicado: (2016)

Hepatoma-derived growth factor and its role in keloid pathogenesis
por: Ooi, BNS, et al.
Publicado: (2010)

High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma
por: Liang, Aijun, et al.
Publicado: (2021)

Bone Marrow Stromal Antigen 2 is a Potential Unfavorable Prognostic Factor for High-Grade Glioma
por: Shi, Haiping, et al.
Publicado: (2020)

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)

Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer
por: Shen, Yanwei, et al.
Publicado: (2017)

Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas
por: Li, Shenglun, et al.
Publicado: (2023)

S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis
por: Wang, Haopeng, et al.
Publicado: (2021)

Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex
por: Bremer, Stephanie, et al.
Publicado: (2013)

Impact of Hepatoma-Derived Growth Factor Blockade on Resiniferatoxin-Induced Neuropathy
por: Wu, Chieh-Hsin, et al.
Publicado: (2021)

Neuroprotective effects of hepatoma-derived growth factor in models of Huntington’s disease
por: Voelkl, Kerstin, et al.
Publicado: (2023)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis
por: Chen, San-Cher, et al.
Publicado: (2015)

Prognostic Nutritional Index Is a Predictive Marker for Health-Related Quality of Life in Patients with Adult Degenerative Scoliosis
por: Zhang, Haoran, et al.
Publicado: (2023)

Discovery of Novel Mono-Carbonyl Curcumin Derivatives as Potential Anti-Hepatoma Agents
por: Cao, Weiya, et al.
Publicado: (2023)

Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma Mice
por: Li, Baohua, et al.
Publicado: (2023)

BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas
por: Gao, Lun, et al.
Publicado: (2023)

Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia
por: Li, Yuqian, et al.
Publicado: (2017)

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival
por: Yang, Jun, et al.
Publicado: (2022)

Role of hepatoma‐derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma
por: Min, Xuejie, et al.
Publicado: (2018)

Hepatoma-Derived Growth Factor-Related Protein-3 Is a Novel Angiogenic Factor
por: LeBlanc, Michelle E., et al.
Publicado: (2015)

Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
por: Tsai, Han-En, et al.
Publicado: (2013)

Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas
por: van Thuijl, Hinke F, et al.
Publicado: (2014)

Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation
por: Sedlmaier, Angela, et al.
Publicado: (2011)

Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma
por: Enomoto, Hirayuki, et al.
Publicado: (2015)

Characterization of Hepatoma-Derived Growth Factor-Related Protein 2 Interactions with Heterochromatin
por: Wistner, Sarah C., et al.
Publicado: (2023)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
por: Meng, Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nm6bid9gaal20ink68qnoqciuo